FREE WEBINAR | Reactivation of EMA Policy 0070: Introduction and key recommendations for a successful Publication

October 9, 2023

EMA Transparency Policy 0070, on the publication of Clinical Data, has been reinstated by EMA this year for new active substances registered under the centralized procedure, becoming effective from this September.

The publication of Clinical Data must follow strategies and techniques defined by the EMA, in order to assure the balance between the protection of personal data whilst maintaining the maximum data utility.

Join Asphalion experts Ivette Camarasa and Nuria García Pazos in this webinar, who will review the latest updates on the policy, timelines, CCI challenges and pre-submission meeting recommendations. They will go over:

  • Latest updates on the policy,
  • Publication and review timelines,
  • CCI challenges
  • Pre-submission meeting recommendations

 

Registrations are open. You can register here: TRANSPARENCY WEBINAR

For further information you can contact us at: [email protected]

 

Event Info

a

Search News & Events

  • Filter by category

Share

Related news and events

NEWS | EMA New Fee Regulation effective January 2025

The European Medicines Agency (EMA) charges fees for the services it provides. As of 1 January 2025, EMA’s fees are governed by Regulation (EU) 2024/568. This is known as the ‘New fee regulation’. Current rules apply still apply until 31 December 2024.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting